Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
Open Access
- 10 February 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 106 (6), 2029-2034
- https://doi.org/10.1073/pnas.0812394106
Abstract
Rett Syndrome (RTT) is a severe form of X-linked mental retardation caused by mutations in the gene coding for methyl CpG-binding protein 2 (MECP2). Mice deficient in MeCP2 have a range of physiological and neurological abnormalities that mimic the human syndrome. Here we show that systemic treatment of MeCP2 mutant mice with an active peptide fragment of Insulin-like Growth Factor 1 (IGF-1) extends the life span of the mice, improves locomotor function, ameliorates breathing patterns, and reduces irregularity in heart rate. In addition, treatment with IGF-1 peptide increases brain weight of the mutant mice. Multiple measurements support the hypothesis that RTT results from a deficit in synaptic maturation in the brain: MeCP2 mutant mice have sparse dendritic spines and reduced PSD-95 in motor cortex pyramidal neurons, reduced synaptic amplitude in the same neurons, and protracted cortical plasticity in vivo. Treatment with IGF-1 peptide partially restores spine density and synaptic amplitude, increases PSD-95, and stabilizes cortical plasticity to wild-type levels. Our results thus strongly suggest IGF-1 as a candidate for pharmacological treatment of RTT and potentially of other CNS disorders caused by delayed synapse maturation.Keywords
This publication has 49 references indexed in Scilit:
- Molecular mechanisms of experience-dependent plasticity in visual cortexPhilosophical Transactions B, 2008
- Deletion of Mecp2 in Sim1-Expressing Neurons Reveals a Critical Role for MeCP2 in Feeding Behavior, Aggression, and the Response to StressNeuron, 2008
- MeCP2, a Key Contributor to Neurological Disease, Activates and Represses TranscriptionScience, 2008
- Role of the brain‐derived neurotrophic factor at glutamatergic synapsesBritish Journal of Pharmacology, 2008
- MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse NumberNeuron, 2007
- Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neuronsNeurobiology of Disease, 2007
- Insulin-Like Growth Factor 1 (IGF-1) Mediates the Effects of Enriched Environment (EE) on Visual Cortical DevelopmentPLOS ONE, 2007
- BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activationNature Neuroscience, 2007
- Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2Proceedings of the National Academy of Sciences of the United States of America, 2007
- Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autismDevelopmental Medicine and Child Neurology, 2006